It's not just broker upgrades sending the CSL share price higher

The CSL Limited (ASX: CSL) share price has been on a tear in June.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price hit a 6-month high of $212.84 today and it's not just because sell side research analysts at the likes of Goldman Sachs and Citigroup remain positive on the company.

Goldmans recently put a $223 12-month share price target on CSL shares that is probably encouraging investors to bid the stock higher given today's level is still around 5% below its target price. 

Another big factor likely supporting CSL is this week's resumption in the fall of the Australian dollar versus the U.S. dollar, with local jobs data today coming in weaker than expected in a result that has seen the Australian dollar fall towards multi-year lows against the greenback. 

This is actually good news for local CSL shareholders though as the company earns the majority of its revenues and profits in U.S. dollars, while reporting in U.S. dollars.

Therefore the lower the Australian dollar falls versus the U.S. dollar the more CSL's profits are worth to local shareholders.

Dividend payments for example are exchanged into Australian dollars for payment to local investors meaning as the Aussie dollar falls the value of the dividend payments rises inversely. 

It's also worth remembering it looks like the Australian dollar will be stuck in a sideways to down trend over the years ahead as analysts expect the Reserve Bank to keep cutting interest rates.

Of course this expectation is partly priced into currency exchange rates already, while CSL shares already trade on a big valuation as the currency outlook is no secret. 

However, for investors the local macro outlook means that buying companies with exposure away from the soft local economy and towards U.S. dollar earners probably still makes sense as a strategy. Share market investing is not rocket science and fortunately some of the best long-term growth companies in the healthcare space tick the boxes.

The likes of CSL, Cochlear Ltd (ASX: COH) and ResMed Inc. (ASX: RMD) are a lot more expensive than just 6 months and I'd strongly suggest they remain on investors' watch lists as high-quality local businesses.

Tom Richardson owns shares of Cochlear Ltd., CSL Ltd., and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man holding out Australian dollar notes, symbolising dividends.
Dividend Investing

These 2 ASX dividend shares are great buys right now

These investments offer investors great buying right now…

Read more »

A man with a heavy facial hair growth and a comical look on his face holds his hands in a 'time out' gesture.
Share Market News

Neuren Pharmaceuticals shares paused pending announcement

Neuren Pharmaceuticals shares are paused from trading as investors await a further announcement from the company.

Read more »

Three workers smiling.
Share Market News

Amcor earnings: Net sales rocket 68% on Berry deal; guidance reaffirmed

Amcor's earnings jump on the Berry deal, with double-digit profit growth and guidance reaffirmed.

Read more »

a group of 3 faceless business men stand together with one extending his hands dramatically as if protesting his treatment or stating his case passionately.
Share Market News

Abacus Storage King weighs management internalisation: What investors need to know

Abacus Storage King launches internalisation talks, creating potential changes for investors.

Read more »

Doctor checking patient's spine x-ray image.
Share Market News

Are these 2 ASX healthcare shares a buying opportunity after yesterday's crash?

ASX healthcare shares have faced headwinds in recent months, but these two could be undervalued.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Share Market News

5 things to watch on the ASX 200 on Wednesday

It looks set to be a tough session for Aussie investors on hump day.

Read more »

Two bidders raise their hands in the air to bid up the price of an ASX 200 share
Share Market News

10 most traded ASX shares among 1 million Aussie investors last year

CMC Markets has more than one million Australian investors registered on its trading platform.

Read more »

A male electricity worker in hard hat and high visibility vest stands underneath large electricity generation towers as he holds a laptop computer and gazes up at the high voltage wires overhead.
Broker Notes

Should you buy this ASX utilities stock before it explodes?

One broker has an optimistic price target on this All Ords stock.

Read more »